We are excited to announce our partnership with SCInvest GmbH, which is based in Liechtenstein and specializes in supporting companies in the field of spinal cord injury.
SCInvest will lead the fundraising efforts for the pilot clinical study on human subjects for the Spinerep technology developed by Neurobiomat.
This collaboration with SCInvest marks a significant milestone in our efforts to advance the potential applications of the Spinerep technology, reinforcing our dedication to pushing the boundaries of medical innovation. We are confident that this partnership will play a crucial role in realizing our research objectives.
Neurobiomat is thrilled to have Mr. Philipp Ruf and Mr. Hugo Baeriswyl, founders of SCInvest, onboard as Ambassadors with whom reflect Neurobiomat's commitment to inclusivity and collaboration within the spinal cord injury community.
Their primary tasks will include promoting the innovative Spinerep technology and actively participating in fundraising efforts to support the upcoming pilot clinical study. Their dedication to raising awareness and advocating for the advancement of spinal cord regeneration aligns perfectly with Neurobiomat's mission.